Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

Similar articles for PubMed (Select 21904690)

1.

Effects of the demethylating agent, 5-azacytidine, on expression of the kallikrein-kinin genes in carcinoma cells of the lung and pleura.

Wong J, Sia YY, Misso NL, Aggarwal S, Ng A, Bhoola KD.

Patholog Res Int. 2011;2011:167046. doi: 10.4061/2011/167046. Epub 2011 Sep 4.

2.

Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma.

Chee J, Singh J, Naran A, Misso NL, Thompson PJ, Bhoola KD.

Biol Chem. 2007 Nov;388(11):1235-42.

PMID:
17976017
3.

Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer.

Chee J, Naran A, Misso NL, Thompson PJ, Bhoola KD.

Biol Chem. 2008 Sep;389(9):1225-33. doi: 10.1515/BC.2008.139.

PMID:
18713009
5.

Expression of the kallikrein/kinin system in human anterior segment.

Webb JG, Yang X, Crosson CE.

Exp Eye Res. 2009 Aug;89(2):126-32. doi: 10.1016/j.exer.2009.02.016. Epub 2009 Mar 4.

6.

Comparison of tissue kallikrein and kinin receptor expression in gastric ulcers and neoplasms.

Sawant S, Snyman C, Bhoola K.

Int Immunopharmacol. 2001 Nov;1(12):2063-80.

PMID:
11710536
7.

Glandular kallikrein gene expression in the human uterus.

Clements J, Mukhtar A, Ehrlich A, Yap B.

Braz J Med Biol Res. 1994 Aug;27(8):1855-63.

PMID:
7749374
8.

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.

Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF.

Int J Cancer. 2003 Aug 20;106(2):198-204.

PMID:
12800194
9.

Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.

Chen H, Suzuki M, Nakamura Y, Ohira M, Ando S, Iida T, Nakajima T, Nakagawara A, Kimura H.

Oncol Rep. 2006 May;15(5):1281-5.

PMID:
16596198
11.

SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.

Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER, Latif F.

Cancer Res. 2002 Oct 15;62(20):5874-80.

12.

Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis.

Takai D, Yagi Y, Wakazono K, Ohishi N, Morita Y, Sugimura T, Ushijima T.

Oncogene. 2001 Nov 8;20(51):7505-13.

13.

Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis.

Cassim B, Shaw OM, Mazur M, Misso NL, Naran A, Langlands DR, Thompson PJ, Bhoola KD.

Rheumatology (Oxford). 2009 May;48(5):490-6. doi: 10.1093/rheumatology/kep016. Epub 2009 Mar 1.

14.

Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.

Bahar A, Bicknell JE, Simpson DJ, Clayton RN, Farrell WE.

Oncogene. 2004 Jan 29;23(4):936-44.

PMID:
14647444
15.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
16.

Kallikrein gene expression in human pituitary tissues.

Clements JA, Mukhtar A, Verity K, Pullar M, McNeill P, Cummins J, Fuller PJ.

Clin Endocrinol (Oxf). 1996 Feb;44(2):223-31.

PMID:
8849579
17.

CpG island methylation and expression of tumour-associated genes in lung carcinoma.

Dammann R, Strunnikova M, Schagdarsurengin U, Rastetter M, Papritz M, Hattenhorst UE, Hofmann HS, Silber RE, Burdach S, Hansen G.

Eur J Cancer. 2005 May;41(8):1223-36.

PMID:
15911247
18.

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.

Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.

Oncogene. 2001 Nov 8;20(51):7573-7.

19.

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.

Clin Cancer Res. 2003 Dec 15;9(17):6389-94.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk